You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

~ Buy the TRIJARDY XR (empagliflozin; linagliptin; metformin hydrochloride) Drug Profile, 2024 PDF Report in the Report Store ~

Litigation for trijardy xr


✉ Email this page to a colleague

« Back to Dashboard


US Court Litigation for trijardy xr

Patent Trial and Appeal Board Cases for trijardy xr

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
8,673,927 Mylan Pharmaceuticals Inc. et al. ⤷  Sign Up 2016-08-10 08-10-2016 DUGI et al Inter partes review ⤷  Sign Up 02-03-2017 ⤷  Sign Up
9,173,859 Mylan Pharmaceuticals Inc. et al. ⤷  Sign Up 2016-08-10 08-10-2016 DUGI et al Inter partes review ⤷  Sign Up 02-03-2017 ⤷  Sign Up
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.